Synapse - Ahmet Dogan

Search Within

Ahmet Dogan

Results (470)

Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis

Journal Article

Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Lacouture, M. E.; Hajdenberg, J.; more...
Haematologica (2018)

Fulltext@MSK | Save

Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma

Journal Article

Ferrufino-Schmidt, M. C.; Medeiros, L. J.; Liu, H.; Clemens, M. W.; Hunt, K. K.; Laurent, C.; Lofts, J.; Amin, M. B.; Ming Chai, S.; Morine, A.; more...
American Journal of Surgical Pathology (2018)

Fulltext@MSK | Save

Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)

Meeting Abstract

Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

Journal Article

Bernatsky, S.; Garcia, H. A. V.; Spinelli, J. J.; Gaffney, P.; Smedby, K. E.; Ramsey-Goldman, R.; Wang, S. S.; Adami, H. O.; Albanes, D.; Angelucci, E.; more...
Lupus Science & Medicine (2017)

Fulltext@MSK | Save

Measurement of PD-1 expression on lymphoma cells by flow cytometry is a useful tool in diagnosing and monitoring minimal residual disease in angioimmunoblastic T-cell lymphoma

Meeting Abstract

Yabe, M.; Ozkaya, N.; Gao, Q.; Pichardo, J.; Huet, S.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
Blood (2017)

Fulltext@MSK | Save

Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM

Meeting Abstract

Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
Blood (2017)

Fulltext@MSK | Save

A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
Blood (2017)

Fulltext@MSK | Save

MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
Blood (2017)

Fulltext@MSK | Save

B-cell maturation antigen is exclusively expressed in a wide range of B-cell and plasma cell neoplasm and in a potential therapeutic target for BCMA directed therapies

Meeting Abstract

Khattar, P.; Pichardo, J.; Jungbluth, A.; Gao, Q.; Smith, E. L.; Roshal, M.; Dogan, A.
Blood (2017)

Fulltext@MSK | Save

Genomic characteristics clinical phenotype and disease course of TP53 mutated diffuse large B cell lymphoma at diagnosis and relapse

Meeting Abstract

Joffe, E.; Batlevi, C. L.; Intlekofer, A. M.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Noy, A.; Straus, D. J.; Portlock, C. S.; Gerecitano, J.; more...
Blood (2017)

Fulltext@MSK | Save